Annelies E. Berden
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The Florence Working Group: An Initiative for a Collaborative Effort to Improve the Classification and Scoring Systems in ANCA-GN.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 21, 2025
Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis.
Journal: Rheumatology (Oxford, England)
Published: September 07, 2024
Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 07, 2023
Technical Developments in ANA Diagnostics: Comparison of a Manual Method to the Visual Readout of Digital Images and Software Analysis.
Journal: The journal of applied laboratory medicine
Published: May 25, 2021
Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 27, 2019
A renal risk score for ANCA-associated glomerulonephritis.
Journal: Kidney international
Published: December 31, 2018
Investigations in systemic vasculitis - The role of renal pathology.
Journal: Best practice & research. Clinical rheumatology
Published: August 22, 2018
Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.
Journal: Rheumatology (Oxford, England)
Published: February 07, 2018
Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.
Journal: PloS one
Published: November 06, 2017
Peripheral Neuropathy, Episodic Rhabdomyolysis, and Hypoparathyroidism in a Patient with Mitochondrial Trifunctional Protein Deficiency.
Journal: JIMD reports
Published: February 26, 2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.
Journal: Arthritis research & therapy
Published: November 24, 2016
Last Updated: 09/26/2026